Safety assessment of rat embryonic fraction for in vivo regenerative therapy
Biology Open · 2024
DOI: 10.1242/bio.060266 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology Open, 2024. Verfasst von Sivarama Prasad Darsi und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biotechnology, School of Life Sciences, Gitam University, Visakhapatnam, AP, India530045. Hauptthemen laut MEDLINE: Regenerative Medicine. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Regenerative therapy is considered a novel option for treating various diseases, whereas a developing embryo is a prime source of molecules that help repair diseased tissue and organs. Organoid culture studies also confirmed the inherent biological functions of several embryonic factors. However, the in vivo safety and efficacy of embryonic protein fraction (EPF) were not validated. In this study, we investigated the effectiveness of EPF on healthy adult rats. We obtained embryos from Sprague-Dawley (SD) female rats of E14, E16, and E19 embryonic days and collected protein lysate. This lysate was administered intravenously into adult SD rats on sequential days. We collected blood and performed hematological and biochemical parameters of rats that received EPF. C-reactive protein levels, interleukin-6, blood glucose levels, serum creatinine, blood urea, total leucocyte counts, and % of neutrophils and lymphocytes were comparable between rats receiving EPF and saline. Histological examination of rats' tissues administered with EPF is devoid of abnormalities. Our study revealed that intravenous administration of EPF to healthy adult rats showed that EPF is non-immunogenic, non-inflammatory, non-tumorigenic, and safe for in vivo applications. Our analysis suggests that EPF or its components could be recommended for validating its therapeutic abilities in organ regenerative therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Biotechnology, School of Life Sciences, Gitam University, Visakhapatnam, AP, India530045.
- Department of Biochemistry, University of Hyderabad, Hyderabad, TG, India500046.
- Department of Veterinary Pharmacology and Toxicology, P.V. Narasimha Rao University of Veterinary Sciences, Rajendra Nagar, TG, India500030.
- Department of General Medicine, ESI Corporation, Gunadala, Vijayawada, AP, India520004.
- Department of Internal Medicine, Banner Health Center, Maricopa, AZ, USA85138.
- Department of Physiology, Apollo Institute of Medical Sciences and Research, Hyderabad, TG 500090, India.
ORCID-Profile: Sivarama Prasad Darsi, Anil Kumar Pasupulati
Zitieren
APA
Darsi, S. P., Baishya, S., Nagati, V., Bharani, K. K., Cheekatla, S. S., Darsi, S. K., Kamireddy, A. R., Barra, R. R., Devarasetti, A. K., Surampudi, S., Singireddy, J. R., Kandula, S. K., & Pasupulati, A. K. (2024). Safety assessment of rat embryonic fraction for in vivo regenerative therapy. Biology Open. https://doi.org/10.1242/bio.060266
Vancouver
Darsi SP, Baishya S, Nagati V, Bharani KK, Cheekatla SS, Darsi SK, et al. Safety assessment of rat embryonic fraction for in vivo regenerative therapy. Biology Open. 2024. doi:10.1242/bio.060266
BibTeX
@article{Darsi2024,
author = {Darsi, Sivarama Prasad and Baishya, Somorita and Nagati, Veerababu and Bharani, Kala Kumar and Cheekatla, Satyanarayana Swamy and Darsi, Sujesh Kumar and Kamireddy, Adi Reddy and Barra, Ram Reddy and Devarasetti, Ashok Kumar and Surampudi, Sreedhar and Singireddy, Jayaram Reddy and Kandula, Siva Kumar and Pasupulati, Anil Kumar},
title = {Safety assessment of rat embryonic fraction for in vivo regenerative therapy},
journal = {Biology Open},
year = {2024},
doi = {10.1242/bio.060266}
}
EUVIMED